News about Logistics&Distribution

Dr Reddy's launches Reddy-Lenalidomide in Canada

Dr Reddy's launches Reddy-Lenalidomide in Canada

Dr Reddy?s Laboratories yesterday launched Reddy-Lenalidomide, a generic equivalent to Revlimid (lenalidomide) capsules in the Canadian market. The product is approved by Health Canada, the company notified in a statement

Logistics&Distribution | 04/09/2021 | By Darshana

NMPB launches national campaign to promote cultivation of medicinal plants

NMPB launches national campaign to promote cultivation of medicinal plants

The National Medicinal Plants Board (NMPB), under the Union Ministry of Ayush, has launched a national campaign to promote cultivation of medicinal plants in the country as part of the Azadi Ka Amrit Mahotsav. This will help in increasing the income of farmers and realize the dream of Green India

Logistics&Distribution | 03/09/2021 | By Darshana

Azerbaijan offers lucrative opportunities for Indian drug exporters

Azerbaijan offers lucrative opportunities for Indian drug exporters

Instructions on the packaging on the drugs in Azerbaijan are allowed to be in four languages -- Russian, English, Turkish and Azerbaijani which create an opportunity to sell drugs intended for the Russian and European market in Azerbaijan, said Uday Bhaskar, director general, Pharmexcil

Logistics&Distribution | 02/09/2021 | By Darshana

Abbott introduces single-dose formulation of carbetocin for prevention of postpartum haemorrhage in India

Abbott introduces single-dose formulation of carbetocin for prevention of postpartum haemorrhage in India

Abbott, the global healthcare company has announced the introduction of a room-temperature-stable, single-dose formulation of carbetocin in India, which is available in convenient vials, to help in the prevention of postpartum haemorrhage (PPH). Abbott?s product is available in the private sector

Logistics&Distribution | 31/08/2021 | By Darshana

CDSCO issues pathway for regularisation of 19 FDCs out of 294 which require further data

CDSCO issues pathway for regularisation of 19 FDCs out of 294 which require further data

The Central Drugs Standard Control Organisation (CDSCO) has issued a pathway for regularisation of 19 fixed dose combinations (FDCs) out of the 294 FDCs which require further generation of data and were licensed by State Licensing Authority (SLA) without prior approval from the Drugs Controller General (India)

Logistics&Distribution | 30/08/2021 | By Darshana

CDSCO declares 44 drug samples as not of standard, one as misbranded in July

CDSCO declares 44 drug samples as not of standard, one as misbranded in July

The Central Drugs Standard Control Organisation (CDSCO) has declared 44 drug samples out of 1028 it has tested as not of standard quality, during the month of July, 2021. Of the samples tested, 983 were declared as of standard quality

Logistics&Distribution | 23/08/2021 | By Darshana

DCGI classifies 135 ophthalmology related medical devices and 51 respiratory medical devices under MD Rules

DCGI classifies 135 ophthalmology related medical devices and 51 respiratory medical devices under MD Rules

The Drugs Controller General (India) has classified 135 medical devices related to ophthalmology under the provisions of Medical Devices Rules, 2017. In another notice, it has also classified 51 medical devices pertaining to respiratory treatments under the provisions of Medical Devices Rules

Logistics&Distribution | 11/08/2021 | By Darshana

Abbott launches Panbio COVID-19 Antigen Self-Test in India

Abbott launches Panbio COVID-19 Antigen Self-Test in India

Abbott has launched Panbio COVID-19 Antigen Self-Test for detecting SARS-CoV-2 virus in adults and children with or without symptoms. In alignment with the current ICMR advisory on self-use, these tests will be made available to ramp up testing of symptomatic and asymptomatic individuals and contacts of confirmed coronavirus cases

Logistics&Distribution | 13/07/2021 | By Darshana

Optima announces new laboratory, scheduling and resource management system

Optima announces new laboratory, scheduling and resource management system

Optima?s algorithm combines all information collected in the system setting and the historical data generated, to provide a scheduling proposal on the best way to coordinate the human and instruments resources to execute the tasks requested and respond to the laboratory?s demand<br />

Logistics&Distribution | 01/07/2021 | By Darshana

Haffkine Biopharma to produce 22.8 crore Covaxin doses per annum

Haffkine Biopharma to produce 22.8 crore Covaxin doses per annum

Haffkine Biopharma, a Maharashtra state PSU proposed to produce 22.8 crore Covaxin doses per annum under technology transfer arrangement with Bharat Biotech. The production will take place at the Parel complex of the company in Mumbai

Logistics&Distribution | 02/06/2021 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology